Background Misinformation about the prevalence of COVID-19 vaccines' side effects (SEs)
has led to concerns about and mistrust of vaccine safety. Thus, this study aimed to evaluate …

Increased COVID‐19 vaccine hesitancy presents a major hurdle in global efforts to contain
the COVID‐19 pandemic. This study was designed to estimate the prevalence of adverse …

Complete heart block (CHB) is a serious health condition, and polyarteritis nodosa (PAN) is
an important autoimmune disease. In the COVID‐19 pandemy, several vaccines were …

Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a
constantly evolving virus, resulting in an increased burden on the existing COVID-19 …

Introduction The lack of local side effect profiles for vaccines could hinder vaccination
uptake. Since all COVID-19 vaccines are brand-new medications, it is crucial to keep track of …

Vaccines are not free from adverse outcomes. However, the evidence of adverse outcomes
following COVID-19 vaccination among health-care professionals (HCPs) in the study …

Introduction: Recent studies have proposed various COVID-19 vaccines to control the
disease and protect susceptible individuals. However, immunogenicity and safety of COVID …

The initial phase of the COVID-19 vaccination in Ecuador occurred between April and
November 2021. Initially, it focused on priority populations, including health professionals …

Introduction: This study assessed the incidence and severity of side effects associated with
coronavirus disease 2019 (COVID-19) vaccination among healthcare workers registered …

Background: Uganda started AstraZeneca COVID-19 vaccination in March 2021 but
information about adverse events is limited. We assessed adverse events following …